Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck?

European Archives of Oto-Rhino-Laryngology

Volumn 267, Issue 10, 2010, Pages 1635-1640

  Haerle, Stephan K ^a   Huber, G F ^a   Hany, T F ^a   Ahmad, N ^a   Schmid, D T ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

FDG PET CT; Head and neck; Squamous cell carcinoma; Standardized uptake value (SUV)

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEASUREMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STANDARDIZED UPTAKE VALUE; TUMOR LOCALIZATION; ADULT; AGED; CANCER STAGING; COHORT ANALYSIS; FEMALE; HEAD AND NECK TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77957016412     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-010-1348-2     Document Type: Article

References (22)

1. K Strobel SK Haerle SJ Stoeckli M Schrank JD Soyka P Veit-Haibach TF Hany 2009 Head and neck squamous cell carcinoma (HNSCC): detection of synchronous primaries with (18)F-FDG-PET/CT Eur J Nucl Med Mol Imaging 36 919 927 10.1007/s00259-009-1064-6 10.1007/s00259-009-1064-6 19205699
2. SK Haerle K Strobel TF Hany D Sidler SJ Stoeckli 2010 (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma Head Neck 32 319 325 10.1002/hed.21184 19626642
3. M Lonneux M Hamoir H Reychler P Maingon C Duvillard G Calais B Bridji L Digue M Toubeau V Gregoire 2010 Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study J Clin Oncol 28 1190 1195 10.1200/JCO.2009.24.6298 10.1200/JCO.2009.24.6298 1:CAS:528:DC%2BC3cXktF2ltbw%3D 20124179
4. CA Uyl-de Groot A Senft R de Bree CR Leemans OS Hoekstra 2010 Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients J Nucl Med 51 176 182 10.2967/jnumed.109.067371 10.2967/jnumed.109.067371 20124045
5. EM Rohren TG Turkington RE Coleman 2004 Clinical applications of PET in oncology Radiology 231 305 332 10.1148/radiol.2312021185 10.1148/radiol. 2312021185 15044750 (Pubitemid 38552885)
6. M Machtay M Natwa J Andrel T Hyslop PR Anne J Lavarino CM Intenzo W Keane 2009 Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer Head Neck 31 195 201 10.1002/hed.20942 10.1002/hed.20942 19107945
7. Maccomb W, Fletcher G (196) Cancer of the head and neck. Williams & Wilkins Company, Baltimore, pp 152-292
8. RB Chen K Suzuki T Nomura T Nakajima 1993 Flow cytometric analysis of squamous cell carcinomas of the oral cavity in relation to lymph node metastasis J Oral Maxillofac Surg 51 397 401 10.1016/S0278-2391(10)80354-4 1:STN:280:DyaK3s7psFKjtg%3D%3D 8450358
9. M Goerkem J Braun SJ Stoeckli 2010 Evaluation of clinical and histomorphological parameters as potential predictors of occult metastases in sentinel lymph nodes of early squamous cell carcinoma of the oral cavity Ann Surg Oncol 17 527 535 10.1245/s10434-009-0755-3 10.1245/s10434-009-0755-3 19834764
10. K Suzuki T Nishioka A Homma K Tsuchiya M Yasuda H Aoyama R Onimaru N Tamaki H Shirato 2009 Value of fluorodeoxyglucose positron emission tomography before radiotherapy for head and neck cancer: does the standardized uptake value predict treatment outcome? Jpn J Radiol 27 237 242 10.1007/s11604-009-0330-7 10.1007/s11604-009-0330-7 19626409
11. Y Sugawara KR Zasadny AW Neuhoff RL Wahl 1999 Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction Radiology 213 521 525 1:STN:280:DC%2BD3c%2FhvV2gsA%3D%3D 10551235
12. DT Schmid SJ Stoeckli F Bandhauer P Huguenin S Schmid GK von Schulthess GW Goerres 2003 Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck Laryngoscope 113 888 891 10.1097/00005537-200305000-00021 10.1097/00005537-200305000-00021 12792328 (Pubitemid 36539165)
13. R Hustinx G Lucignani 2010 PET/CT in head and neck cancer: an update Eur J Nucl Med Mol Imaging 37 645 651 10.1007/s00259-009-1365-9 20187296
14. Y Kitagawa K Sano S Nishizawa M Nakamura T Ogasawara N Sadato Y Yonekura 2003 FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer Eur J Nucl Med Mol Imaging 30 63 71 10.1007/s00259-002-0978-z 10.1007/s00259-002-0978-z 1:CAS:528:DC%2BD38XpsV2iu7w%3D 12483411 (Pubitemid 36692894)
15. W Halfpenny SF Hain L Biassoni MN Maisey JA Sherman M McGurk 2002 FDG-PET. A possible prognostic factor in head and neck cancer Br J Cancer 86 512 516 10.1038/sj.bjc.6600114 10.1038/sj.bjc.6600114 1:CAS:528: DC%2BD38XislCmtr4%3D 11870529 (Pubitemid 34185084)
16. E Brun E Kjellen J Tennvall T Ohlsson A Sandell R Perfekt J Wennerberg SE Strand 2002 FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma Head Neck 24 127 135 10.1002/hed.10037 10.1002/hed.10037 11891942 (Pubitemid 34111509)
17. AS Allal P Dulguerov M Allaoua CA Haenggeli A El-Ghazi el W Lehmann DO Slosman 2002 Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy J Clin Oncol 20 1398 1404 10.1200/JCO.20.5.1398 1:CAS:528:DC%2BD38XisVWmu7Y%3D 11870185 (Pubitemid 34177448)
18. T Torizuka Y Tanizaki T Kanno M Futatsubashi K Naitou Y Ueda Y Ouchi 2009 Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer AJR Am J Roentgenol 192 W156 W160 10.2214/AJR.08.1429 10.2214/AJR.08.1429 19304675
19. DL Schwartz J Rajendran B Yueh MD Coltrera M Leblanc J Eary K Krohn 2004 FDG-PET prediction of head and neck squamous cell cancer outcomes Arch Otolaryngol Head Neck Surg 130 1361 1367 10.1001/archotol.130.12.1361 10.1001/archotol.130.12.1361 15611393 (Pubitemid 39603296)
20. JP Agarwal I Mallick R Bhutani S Ghosh-Laskar T Gupta A Budrukkar V Murthy M Sengar KA Dinshaw 2009 Prognostic factors in oropharyngeal cancer-analysis of 627 cases receiving definitive radiotherapy Acta Oncol 48 1026 1033 10.1080/02841860902845839 10.1080/02841860902845839 19363712
21. JP Ioannidis J Lau 2003 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis J Nucl Med 44 717 724 12732672
22. J Ensley J Crissman J Kish J Jacobs A Weaver J Kinzie G Cummings M Al-Sarraf 1986 The impact of conventional morphologic analysis on response rates and survival in patients with advanced head and neck cancers treated initially with cisplatin-containing combination chemotherapy Cancer 57 711 717 10.1002/1097-0142(19860215)57:4<711::AID-CNCR2820570405>3.0.CO;2-C 1:STN:280:DyaL287gsFKktw%3D%3D 3943009 (Pubitemid 16161046)